Serial 97460834
Live / Registered — Registered (as of 18 Jul 2023)
What this means for you
Registered since 18 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97460834
- Registration number
- 7114062
- Mark type
- Design / logo
- Filed
- 15 Jun 2022
- Published for opposition
- 02 May 2023
- Registered
- 18 Jul 2023
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders
Owner
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
Prosecution history
- 18 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 02 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 May 2023 — PUBLISHED FOR OPPOSITION
- 12 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Mar 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 27 Mar 2023 — USE AMENDMENT ACCEPTED
- 27 Mar 2023 — ASSIGNED TO EXAMINER
- 21 Mar 2023 — AMENDMENT TO USE PROCESSING COMPLETE
- 21 Mar 2023 — USE AMENDMENT FILED
- 20 Mar 2023 — TEAS AMENDMENT OF USE RECEIVED
- 27 Jul 2022 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 26 Jul 2022 — ASSIGNED TO LIE
- 22 Jun 2022 — TEAS VOLUNTARY AMENDMENT RECEIVED